US$35.03+0.2%11月13日 收盘
数据截至2026年9月30日,来自2026年11月4日提交的10-Q
公司指引:2026 财年第 4 季度营收 US$295M 至 US$301M — 同比下降 5.1%(上年同期 US$314M)
Just reported
From Omnicell, Inc.'s results release of 2026年10月29日; its quarterly report has since been filed.
Actual
US$307.9M
-0.9% y/y
-1.4% q/q
Guided
US$304M
midpoint
Actual
US$0.24
+100% y/y
-54% q/q
Guided
—
| 指标 | 截至该日的 3 个月2026年9月30日 | 截至该日的 3 个月2025年9月30日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$307.9M | US$310.6M | -0.89% |
| 利润 | US$11M | US$5.5M | +102.20% |
| 每股收益 | US$0.24 | US$0.12 | +100.00% |
| 自由现金流 | US$21.7M | US$18.5M | +17.15% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
暂无 Omnicell, Inc. 的业绩电话会文字记录。
“We delivered solid third quarter results and continued to execute against our strategic priorities,”
逐字引自公告,且只在文件将其归于具名人士时才展示。
公告在开盘前或收盘后发布,因此区间从公告日前一个交易日的收盘价到公告日之后那个交易日的收盘价——无论哪种情况,反应都包含在内。
Omnicell is a healthcare technology leader focused on advancing autonomous medication management to drive meaningful outcomes across the patient care journey. Through AI-enabled innovation, enterprise intelligence, and scalable automation, we seek to connect and optimize medication management from orders to outcomes, empowering healthcare organizations worldwide to improve efficiency, enhance safety, strengthen financial performance, and deliver better experiences for patients and care teams. Learn more at omnicell.com. From time to time, Omnicell may use the Company’s investor relations website and other online social media channels, including its LinkedIn page www.linkedin.com/company/omnicell, and Facebook page www.facebook.com/omnicellinc, to disclose material non-public information and comply with its disclosure obligations under Regulation Fair Disclosure (“Reg FD”). OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries. This press release may also include the trademarks and service marks of other companies. Such trademarks and service marks are the marks of their respective owners.
公司自己的描述,取自公告末尾。
引述和公司简介来自 Omnicell, Inc. 于 2026年10月29日 提交的第 2.02 项 8-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。
No guide given
Actual
US$14.9M
+81% y/y
-54% q/q
Guided
—
No guide given
Q4 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.